Bluebird bio Rebrands as Genetix Biotherapeutics, Reaffirming Its Commitment to Gene Therapy
Genetix Biotherapeutics, formerly known as Bluebird bio, has officially rebranded, marking a return to its original name from 1992 when […]
New EU Data Act Affects Businesses Across Europe
On September 12, the European Commission’s EU Data Act took effect, requiring many businesses in Europe to rethink how they
New Breakthrough in Narcolepsy Treatment: Boosting Brain Protein Shows Promise
Drug developers worldwide have made exciting progress in treating narcolepsy by focusing on a key brain protein called orexin-2. This
BeOne Medicines Moves to Basel, Joining a Thriving Life Sciences Hub
In May, the oncology company BeOne Medicines, formerly known as BeiGene, relocated its headquarters from China to Basel, Switzerland. According
New Hope for Lung Cancer Patients: NHS Approves Breakthrough Treatment
AstraZeneca’s drug Imfinzi (durvalumab) has been approved for use in England and Wales to treat adults with a specific type
CDC Advisers Recommend Separate Measles and Chickenpox Vaccines for Young Children to Reduce Seizure Risk
A group of experts advising the Centers for Disease Control and Prevention (CDC) recently voted to suggest that young children
Pharmaceutical News
Novo Nordisk Restructures to Focus on Obesity and Diabetes Treatments
Novo Nordisk, a leading pharmaceutical company, is making big changes to focus more on obesity and diabetes treatments. Their CEO
Pharmaceutical News
New In-Line System Improves Tablet Quality Checks in Drug Manufacturing
A new monitoring system has been developed to enhance quality testing during the production of pharmaceutical tablets. This innovation could
Merck & Co Cancels Major UK Research Plans and Cuts Jobs
Merck & Co (also known as MSD outside the US) has decided to cancel its plans for a £1 billion
Pharmaceutical News
US Biotech LB Pharmaceuticals Breaks 2025 IPO Drought with Strong Funding
US-based biotech company LB Pharmaceuticals has successfully raised significant funds through an initial public offering (IPO), breaking a dry spell